Warren Buffett’s Berkshire Hathaway says it is acquiring a “robust portfolio of operating assets” in Occidental’s OxyChem.
Morgan Stanley analysts boosted their target price to $298 but see room for the stock to hit $376 if foldable iPhones and AI spur a big wave of upgrades in the next launch cycle.
A disagreement over Obamacare subsidies has triggered the partial government shutdown that’s now in its second day — and some ...
A fresh worry joined old concerns about Rivian Automotive Inc. on Thursday, dragging down the electric-truck maker’s stock ...
Have an issue with your financial planner or looking for a new one? Email questions or concerns to [email protected].
How can Alphabet’s stock build on its gains? By driving search and cloud momentum that sends earnings estimates higher, a ...
Accountable care organizations — which run like Medicare Advantage plans — get financially penalized when they spend too much ...
CarMax Inc.’s recent profit miss and the stock’s 20% selloff have made analysts at Morgan Stanley question the used-car ...
This chart from Truist's Keith Lerner might help explain why so many professional investors are starting to feel uneasy as ...
He’s used to giving me the silent treatment whenever there is conflict and he’s improved, but there is still a huge divide ...
Follow all the latest U.S. market action for Thursday as the S&P 500 struggles to push higher following a four-day winning streak.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback